Believes Truly Independent Board Required to Increase Accountability Given PharmaCyte's Long History of Missed Milestones
Highlights Severe Governance Deficiencies and Recent Half-Baked Efforts to Appease Stockholders
Read more at prnewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Believes Truly Independent Board Required to Increase Accountability Given PharmaCyte's Long History of Missed Milestones
Highlights Severe Governance Deficiencies and Recent Half-Baked Efforts to Appease Stockholders
Read more at prnewswire.comSymbol | Last | Chg | %Chg |
---|---|---|---|
PMCB | 1.5800 | -0.0900 | -5.39% |
Pharmacyte Biotech Inc |